Prognostic risk score and index including the platelet-to-lymphocyte ratio and lactate dehydrogenase in patients with metastatic or unresectable urothelial carcinoma treated with immune checkpoint inhibitors.
作者:
主题词
人类(Humans);男(雄)性(Male);女(雌)性(Female);回顾性研究(Retrospective Studies);预后(Prognosis);老年人(Aged);中年人(Middle Aged);淋巴细胞(Lymphocytes);血小板(Blood Platelets);L-乳酸脱氢酶(L-Lactate Dehydrogenase);老年人, 80以上(Aged, 80 and over);泌尿系肿瘤(Urologic Neoplasms);肿瘤转移(Neoplasm Metastasis);癌, 移行细胞(Carcinoma, Transitional Cell);淋巴细胞计数(Lymphocyte Count);成年人(Adult)
DOI
10.1093/jjco/hyae137
PMID
39373462
发布时间
2025-02-04
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文